We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
This case report details paradoxical skin lesions caused by Xeligekimab in a patient with SAPHO syndrome, suggesting new insights into treatment responses.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: